Inulin-type fructans in healthy aging

Journal of Nutrition

Volumn 137, Issue 11, 2007, Pages

  Tuohy, Kieran M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTAN; INULIN; PREBIOTIC AGENT; PROBIOTIC AGENT;

AGING; CONFERENCE PAPER; HUMAN; INTESTINE FLORA; AGED; ANIMAL; DRUG EFFECT; GERIATRICS; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; PHYSIOLOGY; REVIEW;

BACTERIA (MICROORGANISMS);

AGED; AGING; ANIMALS; FRUCTANS; GERIATRICS; HUMANS; INTESTINES; INULIN;

EID: 35848950211     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/137.11.2590s     Document Type: Conference Paper

References (40)

1. Kalache A. Active ageing makes the difference. Bull World Health Organ. 1999;77:299.
2. Garibaldi RA, Nurse BA. Infections in the elderly. Am J Med. 1986;81:53-8.
3. Hébuterne X. Gut changes attributed to ageing: effects on intestinal microbiota. Curr Opin Clin Nutr Metab Care. 2003;6:49-54.
4. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science. 2005;308:1635-8.
5. Wang Y, Lawler D, Larson B, Ramadan Z, Kochhar S, Holmes E, Nicholson JK. Metabonomic investigations of aging and caloric restriction in a life-long dog study. J Proteome Res. 2007;6:1846-54.
6. Gorbach SL, Nahas L, Lerner PI, Weinstein L. Studies of intestinal microbiota. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology. 1967;53:845-55.
7. Mitsuoka T, Hayakawa K. The fecal flora in man. I. Composition of the fecal flora of various age groups. Zentralbl Bakteriol. 1973;223:333-42.
8. Mitsuoka T. Intestinal flora and aging. Nutr Rev. 1992;50:438-46.
9. Benno Y, Nakao H, Uchida K, Mitsuoka T. Impact of the advances in age on the gastrointestinal microbiota of beagle dogs. J Vet Med Sci. 1992;54:703-6.
10. Saunier K, Doré J. Gastrointestinal tract and the elderly: functional foods, gut microbiota and healthy ageing. Dig Liver Dis. 2002;34:S19-24.
11. Blaut M, Collins MD, Welling GW, Doré J, van Loo J, de Vos W. Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Br J Nutr. 2002;87:S203-11.
12. Saunier K, Tuohy K, Sutren M, Cresci A, Doré J. Culture independent molecular analysis of the elderly fecal microbiota reveals an extreme complexity. Reprod Nutr Dev. 2002;42 Suppl 1:S8-9.
13. Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial populations assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut. 2001;48:198-205.
14. Hopkins MJ, Macfarlane GT. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol. 2002;51:448-54.
15. Silvi S, Verdenelli MC, Orpianesi C, Cresci A. EU project CROWNA-LIFE: functional foods, gut microbiota and healthy ageing isolation and identification of Lactobacillus and Bifidobacterium strains from faecal samples of elderly subjects for a possible probiotic use in functional foods. J Food Eng. 2003;56:195-200.
16. Likotrafiti E, Manderson KS, Fava F, Tuohy KM, Gibson GR, Rastall RA. Molecular identification and anti-pathogenic activities of putative probiotic bacteria isolated from faeces of healthy elderly individuals. Microb Ecol Health Dis. 2004;16:105-12.
17. Dunne C, Murphy L, Flynn S, O'Mahony L, O'Halloran S, Feeney M, Morrissey D, Thornton G, Fitzgerald G, et al. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Leeuwenhoek. 1999;76:279-92.
18. Gavini F, Cayuela C, Antoine JM, Lecoq C, Lefebvre B, Membré B, Neut C. Differences in the distribution of bifidobacterial and enterobacterial species in human faecal microbiota of three different (children, adults, elderly) age groups. Microb Ecol Health Dis. 2001;13:40-5.
19. Mueller S, Saunier K, Hanisch C, Norin E, Alm L, Midtvedt T, Cresci A, Silvi S, Orpianesi C, et al. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol. 2006;72:1027-33.
20. Gibson GR, Roberfroid MB. Dietary modulation of the colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125:1401-12.
21. Tuohy KM, Rouzaud GCM, Brück WM, Gibson GR. Modulation of the human gut microbiota towards improved health using prebiotics assessment of efficacy. Curr Pharm Des. 2005;11:75-90.
22. Roberfroid MB, van Loo JA, Gibson GR. The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr. 1998;128:11-9.
23. Roberfroid M. Functional food concept and its application to prebiotics. Dig Liver Dis. 2002;34 Suppl 2:S105-10.
24. Hoentjen F, Welling GW, Harmsen HJ, Zhang X, Snart J, Tannock GW, Lien K, Churchill TA, Lupicki M, et al. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis. 2005;11:977-85.
25. Furrie E, Macfarlane S, Kennedy A, Cummings JH, Walsh SV, O'Neil DA, Macfarlane GT. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut. 2005;54:242-9.
26. Guarner F. Inulin and oligofructose: impact on intestinal diseases and disorders. Br J Nutr. 2005;93 Suppl 1:S61-5.
27. Femia AP, Luceri C, Dolara P, Giannini A, Biggeri A, Salvadori M, Clune Y, Collins KJ, Paglierani M, et al. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis. 2002;23:1953-60.
28. Verghese M, Rao DR, Chawan CB, Shackelford L. Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature Fisher 344 rats. J Nutr. 2002;132:2804-8.
29. Jacobsen H, Poulsen M, Dragsted LO, Ravn-Haren G, Meyer O, Lindecrona RH. Carbohydrate digestibility predicts colon carcinogenesis in azoxymethane-treated rats. Nutr Cancer. 2006;55:163-70.
30. Pool-Zobel BL. Inulin-type fructans and reduction in colon cancer risk: review of experimental and human data. Br J Nutr. 2005;93 Suppl 1:S73-90.
31. Jackson KG, Taylor GR, Clohessy AM, Williams CM. The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br J Nutr. 1999;82:23-30.
32. Beylot M. Effects of inulin-type fructans on lipid metabolism in man and in animal models. Br J Nutr. 2005;93 Suppl 1:S163-8.
33. Rault-Nania MH, Gueux E, Demougeot C, Demigne C, Rock E, Mazur A. Inulin attenuates atherosclerosis in apolipoprotein E-deficient mice. Br J Nutr. 2006;96:840-4.
34. Abrams SA, Griffin IJ, Hawthorne KM, Liang L, Gunn SK, Darlington G, Ellis KJ. A combination of prebiotic short- and long-chain inulintype fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr. 2005;82:471-6.
35. Nzeusseu A, Dienst D, Haufroid V, Depresseux G, Devogelaer JP, Manicourt DH. Inulin and fructo-oligosaccharides differ in their ability to enhance the density of cancellous and cortical bone in the axial and peripheral skeleton of growing rats. Bone. 2006;38:394-9.
36. Gibson GR, Beatty ER,Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology. 1995;108:975-82.
37. Asahara T, Nomoto K, Shimizu K, Watanuki M, Tanaka R. Increased resistance of mice to Salmonella enterica serovar Typhimurium infection by synbiotic administration of bifidobacteria and transgalactooligosaccharides. J Appl Microbiol. 2001;91:985-96.
38. Kleessen B, Sykura B, Zunft HJ, Blaut M. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr. 1997;65:1397-402.
39. Bartosch S, Woodmansey EJ, Paterson JC, McMurdo ME, Macfarlane GT. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis. 2005;40:28-37.
40. Nicholson JK, Holmes E, Wilson ID. Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol. 2005;3:431-8.